<div>
  <ul>
    <li>
      <p>
        Mydecine Innovations Group has released its Q1 2023 earnings, reporting a net loss per share of USD 0.41. The company&rsquo;s net losses for the quarter increased by 35.9% YoY to USD 7.7 million.
      </p>
    </li>
    <li>
      <p>
        Total expenses for the quarter were USD 4.0 million (down 16% YoY), primarily due to a reduction in R&amp;D expenses by 86.3% YoY, as well as reduced professional fees in the same quarter.
      </p>
    </li>
    <li>
      <p>
        As of March 31, 2023, the company&rsquo;s cash, cash equivalents, and investments stood at USD 10,000. The company did not provide any financial guidance for 2023.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.globenewswire.com/news-release/2023/05/16/2670411/0/en/Mydecine-Reports-Financial-Results-for-the-First-Quarter-of-Fiscal-Year-2023.html">
      Company press release
    </a>
  </p>
</div>


Psychedelic Medicine

Mydecine provides financial update for Q1 2023; net losses deepen

Mydecine raises USD 0.7 million in the eighth tranche of common share subscription agreement

Artificial intelligence is identifying and testing new therapies faster than ever.

AI Drug Discovery

Mydecine files prospectus for USD 4.5 million; closes first tranche

A new industry proving that digital connectivity and mental health can co-exist.

All Updates

Mydecine provides financial update for Q1 2023; net losses deepen

Mydecine raises USD 0.7 million in the eighth tranche of common share subscription agreement

Mydecine raises USD 0.7 million in the eighth tranche of common share subscription agreement

Mydecine files prospectus for USD 4.5 million; closes first tranche

PanGenomic Health acquires Mindleap Health

PanGenomic Health acquires Mindleap Health

Mydecine provides clinical and business updates for Q3 2022

Wesana and Mydecine sell off subsidiaries to enhance business focus

Mydecine to raise USD 10 million from third-party investor

Mydecine announces private placement; CFO resigns